CEO Robert Davis stated that "We continue to make meaningful progress in using the power of leading-edge science to save and improve lives around the world," highlighting approximately 80 Phase III ...

Merck MRK reported first-quarter 2025 adjusted earnings per share (EPS) of $2.22, which beat the Zacks Consensus Estimate of $2.15. Earnings rose 7% year over year on a reported basis and 12% ...

Merck shares tumbled Tuesday morning after the drugmaker's soft outlook outweighed fourth-quarter revenue and adjusted ...

Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry.

Add Yahoo as a preferred source to see more of our stories on Google. Merck KGaA's antibody-drug conjugate (ADC) Merck KGaA's antibody-drug conjugate (ADC), precemtabart tocentecan (Precem-TcT), has ...

Good morning, everyone, here in Darmstadt at the Merck Innovation Center and from Darmstadt into the world and a warm welcome to our annual of Merck press conference. My name is Axel Lober, I'm Head ...

By Julie Steenhuysen CHICAGO, July 30 (Reuters) - Hilleman Laboratories, a Singapore-based joint venture between Merck and ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the broader biopharma industry. For the full year, Merck now expects sales ...

Forbes contributors publish independent expert analyses and insights. As a brief background, Merck develops pharmaceutical products for human health across various therapeutic areas and also creates ...

Merck is recognized for its extensive product portfolio covering treatments in areas like oncology, diabetes, cardiovascular diseases, vaccines, and infectious diseases. The company also operates a ...

Technology is changing the way pharmaceutical companies discover and develop new drugs. For Matt Studney, who joined Merck as a chemical engineer, technology changed the course of his career. In 2017, ...